ArticleTherapeutic advances in medical oncology2013

Targeted approach to metastatic colorectal cancer: what comes beyond epidermal growth factor receptor antibodies and bevacizumab?

Teresa Troiani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.